Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Patent
1977-09-08
1979-01-02
Tovar, Jose
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
2603067R, 260307C, 260326N, 260326C, 260326R, 544322, 544331, A61K 3142, C07D41304
Patent
active
041327993
ABSTRACT:
Tricyclicdicarboximides representatively prepared by the Diels-Alder condensation of a cyclic diene such as cycloheptatriene, cyclooctatetraene and the like with a dienophile such as substituted N-phenylmaleimide and the like are disclosed having pharmaceutical utility as minor tranquilizers and anti-convulsants. Also disclosed are processes for the preparation of such tricyclicdicarboximides; pharmaceutical compositions comprising such compounds and their salt, ester and amide derivatives; and methods of treatment comprising administering such compounds and compositions.
REFERENCES:
patent: 3126395 (1964-03-01), Kitahonoki et al.
patent: 3476546 (1969-11-01), Roberts et al.
patent: 3625946 (1971-12-01), Koch et al.
patent: 3770761 (1973-11-01), Bretschneider et al.
Paleveda, Jr. William J.
Shepard Kenneth L.
Arno James A.
Merck & Co. , Inc.
Nicholson William H.
Tovar Jose
Turnipseed James H.
LandOfFree
N-(Benzoxazolinyl-2-one)-tricyclic dicarboximides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-(Benzoxazolinyl-2-one)-tricyclic dicarboximides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(Benzoxazolinyl-2-one)-tricyclic dicarboximides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1517997